Concurrent Investment Advisors LLC boosted its holdings in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 737.3% during the 2nd quarter, Holdings Channel reports. The fund owned 30,577 shares of the real estate investment trust’s stock after buying an additional 26,925 shares during the period. Concurrent Investment Advisors LLC’s holdings in Ventas were worth $2,715,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in VTR. Dynamic Wealth Strategies LLC bought a new stake in shares of Ventas in the 1st quarter valued at about $25,000. Wiser Advisor Group LLC bought a new position in shares of Ventas during the third quarter valued at approximately $27,000. Silvant Capital Management LLC bought a new position in shares of Ventas during the second quarter valued at approximately $28,000. Meeder Asset Management Inc. purchased a new position in Ventas during the second quarter valued at approximately $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new position in Ventas during the fourth quarter valued at approximately $30,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Stock Down 0.4%
VTR stock opened at $89.94 on Wednesday. The firm has a 50 day moving average of $92.99 and a 200 day moving average of $87.89. The stock has a market capitalization of $46.13 billion, a PE ratio of 166.55, a price-to-earnings-growth ratio of 3.52 and a beta of 0.70. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas, Inc. has a 52 week low of $66.54 and a 52 week high of $101.60.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. BMO Capital Markets upped their target price on Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a report on Tuesday, August 11th. Mizuho lifted their price target on Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. Jefferies Financial Group upped their price objective on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $110.00 price objective on shares of Ventas in a research report on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $99.00.
Read Our Latest Stock Report on Ventas
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
